ABIVAX Société Anonyme
EPA:ABVX.PA
9.55 (EUR) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4.621 | 4.583 | 0.037 | 0.014 | -0.007 | 0.815 | 0.356 | 0.151 | 0.228 | 0.067 | 0.075 |
| Cost of Revenue
| 0.707 | 0.071 | 0.156 | 0.066 | 0.08 | 15.376 | 10.472 | 14.645 | 14.752 | 0.286 | 0.161 |
| Gross Profit
| 3.914 | 4.512 | -0.119 | -0.052 | -0.087 | -14.561 | -10.116 | -14.494 | -14.524 | -0.219 | -0.086 |
| Gross Profit Ratio
| 0.847 | 0.985 | -3.216 | -3.714 | 12.429 | -17.866 | -28.416 | -95.987 | -63.702 | -3.268 | -1.15 |
| Reseach & Development Expenses
| 103.176 | 48.725 | 47.202 | 34.526 | 29.007 | 15.868 | 10.846 | 15.459 | 15.267 | 0.004 | 0 |
| General & Administrative Expenses
| 13.298 | 49.606 | 5.58 | 33.278 | 27.69 | 14.918 | 10.038 | 14.233 | 13.876 | 6.159 | 5.471 |
| Selling & Marketing Expenses
| 0.709 | 0.41 | -0.831 | -28.299 | -23.561 | -10.62 | -6.256 | -10.675 | -10.452 | 0 | 0 |
| SG&A
| 28.114 | 7.902 | 4.749 | 4.979 | 4.129 | 4.298 | 3.782 | 3.558 | 3.424 | 6.159 | 5.471 |
| Other Expenses
| 3.198 | 0.052 | -0.08 | -0.024 | -0.059 | -0.065 | -0.104 | 0.047 | -0.056 | 0 | 0 |
| Operating Expenses
| 131.29 | 56.575 | 52.031 | 39.529 | 33.195 | 4.786 | 3.883 | 3.603 | 4.198 | 8.638 | 7.311 |
| Operating Income
| -131.997 | -56.646 | -52.187 | -39.595 | -33.275 | -19.109 | -14.15 | -18.236 | -18.255 | -8.857 | -7.397 |
| Operating Income Ratio
| -28.565 | -12.36 | -1,410.459 | -2,828.214 | 4,753.571 | -23.447 | -39.747 | -120.768 | -80.066 | -131.929 | -98.798 |
| Total Other Income Expenses Net
| -24.857 | -0.38 | 6.626 | -0.531 | -1.595 | -0.687 | 0.236 | 0.409 | -0.533 | -0.805 | 0.428 |
| Income Before Tax
| -152.233 | -74.322 | -45.561 | -40.126 | -34.891 | -19.793 | -13.914 | -17.827 | -18.789 | -8.957 | -7.558 |
| Income Before Tax Ratio
| -32.944 | -16.217 | -1,231.378 | -2,866.143 | 4,984.429 | -24.286 | -39.084 | -118.06 | -82.408 | -133.418 | -100.945 |
| Income Tax Expense
| -4.493 | -4.476 | -4.204 | -2.575 | -4.257 | 3.97 | 2.692 | 3.519 | 2.834 | -1.561 | -1.665 |
| Net Income
| -147.74 | -69.846 | -41.357 | -37.551 | -30.634 | -15.823 | -11.222 | -14.308 | -15.955 | -8.099 | -5.894 |
| Net Income Ratio
| -31.971 | -15.24 | -1,117.757 | -2,682.214 | 4,376.286 | -19.415 | -31.522 | -94.755 | -69.978 | -120.645 | -78.715 |
| EPS
| -3.43 | -3.13 | -2.47 | -2.62 | -2.51 | -1.56 | -1.14 | -1.48 | -1.65 | -1,171.27 | -852.28 |
| EPS Diluted
| -3.43 | -3.13 | -2.47 | -2.62 | -2.51 | -1.55 | -1.13 | -1.47 | -1.64 | -1,171.27 | -852.28 |
| EBITDA
| -133.207 | -53.315 | -42.195 | -39.53 | -33.215 | -19.227 | -14.057 | -17.731 | -18.119 | -5.005 | -7.375 |
| EBITDA Ratio
| -28.412 | -12.345 | -1,406.243 | -2,823.5 | 4,742.143 | -23.36 | -39.486 | -120.331 | -79.469 | -129.566 | -98.494 |